Jaiprakash Power Ventures Limited (NSE:JPPOWER)

Ligand Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	8,925	310.4	586.1	619.4	401.9
Accounts Receivable	-	9,432	11,864	13,830	10,396	7,909
Other Receivables	-	873.2	287.9	74.7	70.1	409.6
Inventory	-	5,825	5,236	7,122	5,187	1,999
Prepaid Expenses	-	192.3	191.8	313.7	267.4	166.6
Other Current Assets	-	12,925	14,654	8,755	8,502	5,214
Total Current Assets	-	38,174	32,544	30,682	25,042	16,100
Property, Plant & Equipment	-	127,587	130,652	136,139	140,304	145,001
Goodwill	-	1.6	1.6	1.6	1.6	1.6
Other Intangible Assets	-	1,863	1,810	1,900	1,670	1,826
Long-Term Deferred Tax Assets	-	-	-	221.6	1,204	2,284
Other Long-Term Assets	-	10,231	8,026	4,127	5,244	4,724
Total Assets	-	177,856	173,033	173,071	173,465	169,937
Accounts Payable	-	2,215	3,617	4,195	3,315	2,261
Accrued Expenses	-	5,359	5,255	7,773	4,898	3,468
Short-Term Debt	-	4,160	4,119	4,156	4,387	4,653
Current Portion of Long-Term Debt	-	1,075	2,051	3,472	1,807	100
Current Unearned Revenue	-	433.1	433.1	3,692	3,438	433.1
Current Portion of Leases	-	18	24.2	22.6	22.6	21.2
Current Income Taxes Payable	-	14.5	33.7	88.5	71.3	63.2
Other Current Liabilities	-	2,551	2,344	2,439	3,776	4,784
Total Current Liabilities	-	15,825	17,877	25,838	21,714	15,783
Long-Term Debt	-	32,422	36,248	39,917	44,513	47,515
Long-Term Leases	-	108.3	18.3	38.3	53.7	67.9
Long-Term Unearned Revenue	-	1,538	1,971	2,404	2,837	3,270
Pension & Post-Retirement Benefits	-	105.4	4.4	-	1.5	-
Long-Term Deferred Tax Liabilities	-	4,682	1,846	-	-	-
Other Long-Term Liabilities	-	364.9	392.5	419.1	452.8	480.5
Total Liabilities	-	55,044	58,356	68,616	69,572	67,116
Total Preferred Equity	38,055	38,055	38,055	38,055	38,055	38,055
Common Stock	-	68,535	68,535	68,535	68,535	68,535
Additional Paid-In Capital	-	2,208	2,208	2,208	2,208	2,208
Retained Earnings	-	-14,552	-22,688	-32,907	-33,461	-34,536
Comprehensive Income & Other	-	28,566	28,566	28,564	28,556	28,558
Total Common Equity	84,757	84,757	76,621	66,400	65,838	64,765
Shareholders' Equity	122,812	122,812	114,676	104,455	103,893	102,821
Total Liabilities & Equity	-	177,856	173,033	173,071	173,465	169,937
Total Debt	37,783	37,783	42,460	47,606	50,784	52,357
Net Cash (Debt)	-28,857	-28,857	-42,150	-47,020	-50,164	-51,955
Net Cash Per Share	-3.15	-3.17	-4.51	-6.86	-7.32	-7.59
Filing Date Shares Outstanding	8,972	6,853	6,853	6,853	6,853	6,853
Total Common Shares Outstanding	8,972	6,853	6,853	6,853	6,853	6,853
Working Capital	-	22,349	14,667	4,843	3,328	317.3
Book Value Per Share	12.37	12.37	11.18	9.69	9.61	9.45
Tangible Book Value	82,892	82,892	74,810	64,498	64,167	62,938
Tangible Book Value Per Share	12.09	12.09	10.92	9.41	9.36	9.18
Land	-	1,245	1,148	1,148	1,148	1,148
Buildings	-	17,011	16,949	16,871	16,745	16,738
Machinery	-	161,594	160,269	159,603	159,293	159,242
Construction In Progress	-	1,829	1,943	3,803	3,950	4,110

Source: S&P Global Market Intelligence. Utility template. Financial Sources.